Karen has extensive experience advising clients on pharmaceuticals, biotechnology, food and drug law and intellectual property issues. She brings deep technical skills to clients’ work in therapeutics, molecular biology, immunology, regenerative medicine, personalized and precision medicine, vaccines and drug delivery systems, making her go-to counsel for patent protection issues of all kinds.

Karen has substantial experience in all aspects of patents, including drafting and prosecution, and regulatory issues relating to acquiring, maintaining and defending patent rights. She also provides advice on risk management of intellectual property and regulatory matters. For investors interested in life science companies, Karen assists in evaluating technologies and intellectual property portfolios.

Karen is a registered patent agent in the United States and Canada. Having worked in the United States previously, Karen is one of a handful of patent agents residing in Canada who has passed both the U.S. and Canadian patent agent exams and is allowed to represent any applicant before the United States Patent and Trademark Office and the Canadian Intellectual Property Office.

CARE Congress on Biosimilars – Central